高级检索
曹志强, 卢莉, 张卫, 李娟, 温小菁, 吴疆. 新型冠状病毒疫苗对奥密克戎变异株免疫保护效果研究进展[J]. 中国公共卫生, 2022, 38(9): 1224-1228. DOI: 10.11847/zgggws1139775
引用本文: 曹志强, 卢莉, 张卫, 李娟, 温小菁, 吴疆. 新型冠状病毒疫苗对奥密克戎变异株免疫保护效果研究进展[J]. 中国公共卫生, 2022, 38(9): 1224-1228. DOI: 10.11847/zgggws1139775
CAO Zhi-qiang, LU Li, ZHANG Wei, . Immunological and preventive effects of COVID-19 vaccine against Omicron variant – a review of research progress[J]. Chinese Journal of Public Health, 2022, 38(9): 1224-1228. DOI: 10.11847/zgggws1139775
Citation: CAO Zhi-qiang, LU Li, ZHANG Wei, . Immunological and preventive effects of COVID-19 vaccine against Omicron variant – a review of research progress[J]. Chinese Journal of Public Health, 2022, 38(9): 1224-1228. DOI: 10.11847/zgggws1139775

新型冠状病毒疫苗对奥密克戎变异株免疫保护效果研究进展

Immunological and preventive effects of COVID-19 vaccine against Omicron variant – a review of research progress

  • 摘要: 新型冠状病毒(新冠病毒)奥密克戎变异株自2021年11月被发现后,快速地在世界各地广泛传播,目前已成为全球新冠病毒传播的主要流行毒株。在奥密克戎变异株大流行的背景下,以新冠病毒原型株为基础构建的新型冠状病毒疫苗(新冠病毒疫苗)对奥密克戎变异株感染的免疫保护效果成为了全球关注的焦点,许多学者围绕不同类型新冠病毒疫苗及不同免疫策略开展了新冠病毒疫苗对奥密克戎变异株免疫保护效果的研究,以观察疫苗对奥密克戎变异株感染的保护作用。本文系统地概述了2021年11月1日 — 2022年7月26日发表的关于新冠病毒疫苗对奥密克戎变异株免疫学效果和保护效果的研究报道,为新冠病毒疫苗接种策略的优化调整及其研发等公共卫生决策提供参考依据。

     

    Abstract: Since the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant in November 2021, the coronavirus diseases 2019 (COVID-19) epidemics caused by the variant has rapidly spread all over the world and the variant become the dominant strain in SARS-CoV-2 infections. Under the Omicron variant-induced pandemic, the effects of COVID-19 vaccine based on the ancestral strain has been brought to researches' attention around the world and many scholars have carried out researches on the immunological and preventive effects of different COVID-19 vaccines on the Omicron variant and immunization strategies. Reviewing literatures published from November 1st, 2021 to July 26th, 2022, the study systematically discussed immunological and preventive effects of COVID-19 vaccines on Omicron variant infections for providing a reference to public health decisions such as vaccination strategy optimization and research development.

     

/

返回文章
返回